Circassia Ltd Company Profile
Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies. These include a new class of T-cell vaccines designed to treat a broad range of allergies, and therapies to combat autoimmune conditions such as rheumatoid arthritis and psoriasis. The Company has made rapid progress since its establishment in 2006, and several of its products are currently in mid- to late-stage development, having successfully completed a number of phase II clinical studies.
Circassia was originally founded to develop and commercialise a range of allergy T-cell vaccines based on the Company’s proprietary ToleroMune® technology, which has the potential to transform current treatment. With its portfolio of allergy T-cell vaccines progressing rapidly through clinical development, Circassia has broadened its pipeline into other areas of immunotherapy. These include treatments for
Circassia is managed by a strong team of life science entrepreneurs and scientists, and is chaired by Sir Richard Sykes, the former Chairman of GlaxoSmithKline. The management team brings a wealth of experience from major pharmaceutical and biotechnology companies as well as the specialty pharmaceutical sector. Circassia is well funded having raised £60m in April 2011 and is supported by a syndicate of leading institutional and venture capital investors.
Location
Magdalen Centre
The Oxford Science Park
Oxford
Oxfordshire
OX4 4GA
UK
Contact
Phone: +44 (0)1865 784574
Fax: +44 (0)1865 784576
Email: Charlesswingland@circassia.co.uk
News Articles
Circassia’s cat allergy treatment shows sustained symptom improvement
Imperial Innovations Group plc announced that portfolio company Circassia has seen strong results from its follow up phase II clinical trial. Patients saw a sustained improvement of their cat allergy...
Circassia appoints Stewart Sharpe as VP Commercial Operations
Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. Sharpe, who has extensive experience of lead...
Circassia appoints GSK’s Dr Brett Haumann
Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia from GlaxoSmithKline where he was vice presiden...
Circassia initiates phase III trial for cat allergy treatment
Imperial Innovations Group plc announced that its portfolio company, Circassia has initiated a pivotal large-scale phase III clinical study of its ToleroMune® cat allergy treatment. Circassia’s pha...
25 February 2013: Oxford, UK and San Antonio, USA – Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing ...
Circassia Appoints Stewart Sharpe as Vice President Commercial Operations (News)
18 September 2012: OXFORD, UK - Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the appointment of Stewart Sharpe to the newly-created position of Vice ...
OXFORD, England and SAN ANTONIO, February 25, 2013 /PRNewswire/ --Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study show...
Circassia Appoints Dr Jean-Jacques Garaud to its Board of Directors (News)
06 December 2012: OXFORD, UK – Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the appointment of Dr Jean-Jacques Garaud MD to its Board of ...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies. These include a new class of T-cell vaccines designed to treat a broad range of allergies, and t...
More Information about "Circassia Ltd" on BioPortfolio
We have published hundreds of Circassia Ltd news stories on BioPortfolio along with dozens of Circassia Ltd Clinical Trials and PubMed Articles about Circassia Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Circassia Ltd Companies in our database. You can also find out about relevant Circassia Ltd Drugs and Medications on this site too.
